Centrifugation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Centrifugation Market is projected to grow from USD 8.75 Billion in 2025 to USD 11.81 Billion by 2031, reflecting a CAGR of 5.13%. Centrifugation is a mechanical technique that employs centrifugal force to isolate particles from a solution based on distinct physical characteristics such as size, viscosity, and density. This market is primarily driven by the expanding biopharmaceutical industry, particularly the rising need for effective separation technologies in vaccine production and drug discovery. This growth is further supported by the essential requirements of blood banks for component fractionation and the increasing use of these systems in clinical diagnostics. As noted by the 'International Federation of Pharmaceutical Manufacturers and Associations' in '2024', 'there were more than 12,700 medicines in various stages of development globally', a statistic that highlights the robust research environment stimulating the procurement of laboratory separation equipment.

However, a major obstacle potentially hindering market growth is the high capital and maintenance cost linked to advanced centrifugation systems. The need for frequent rotor calibration, expensive component replacements, and specialized technical maintenance places a significant financial strain on smaller independent laboratories and healthcare facilities, especially in budget-constrained regions. These expenses can limit the widespread adoption of high-speed centrifuges and ultracentrifuges.

Market Drivers

The growing incidence of chronic and infectious diseases acts as a primary catalyst for the Global Centrifugation Market, creating a need for enhanced research and diagnostic capabilities. As rates of conditions such as cancer and blood disorders rise, clinical laboratories and research institutions require high-performance centrifugation systems to precisely separate biological samples, including DNA, cellular materials, and blood components, which are vital for accurate diagnosis and treatment strategies. This increasing disease burden directly correlates with the demand for reliable laboratory equipment to manage higher testing volumes. The American Cancer Society's 'Cancer Facts & Figures 2024', released in January 2024, projects that new cancer diagnoses in the United States will exceed 2 million for the first time, underscoring the critical need for robust diagnostic infrastructure.

At the same time, the market is significantly influenced by expanding pharmaceutical and biotechnology research and development (R&D) activities aimed at discovering novel therapeutics and vaccines. Centrifuges are indispensable in these R&D workflows, utilized for protein purification, cell harvesting, and the isolation of active pharmaceutical ingredients.

The intensifying focus on personalized medicine and biologics has led to increased investment in laboratory technologies that ensure yield and purity. According to the European Federation of Pharmaceutical Industries and Associations' 'The Pharmaceutical Industry in Figures 2024' from June 2024, the research-based biopharmaceutical industry is estimated to have invested €50.00 billion in R&D in Europe in 2023. Furthermore, government initiatives are reinforcing this growth; the UK Government announced a £520 million commitment in 2024 for the Life Sciences Innovative Manufacturing Fund to secure major investments and support the production of life-saving medicines.

Market Challenges

The significant capital and maintenance expenses associated with advanced centrifugation systems represent a major barrier to the growth of the global market. High-performance units, particularly ultracentrifuges used in genomic and proteomic research, require a substantial upfront investment that strains the budgets of small-to-medium-sized laboratories and independent healthcare facilities. Beyond the initial purchase price, the total cost of ownership is increased by the strict requirement for regular rotor calibration and specialized technical servicing to ensure safety and precision. These ongoing operational costs often force procurement departments to postpone upgrading aging machinery, thereby slowing the replacement cycle necessary for market expansion.

Financial pressures on healthcare providers further exacerbate this issue, limiting the funds available for new capital equipment. The 'American Hospital Association' reported in '2025' that '94% of health care administrators expect to delay equipment upgrades to manage financial strain'. This fiscal conservatism directly impacts the centrifugation market by reducing the adoption rate of newer technologies in cost-sensitive regions. Consequently, laboratories frequently opt to extend the lifespan of existing units rather than investing in modern systems, creating a measurable drag on overall industry revenue growth.

Market Trends

The increasing adoption of single-use centrifugation systems in biopharmaceutical manufacturing is fundamentally altering downstream processing workflows. As the demand for biologics and cell therapies grows, manufacturers are shifting away from traditional stainless-steel equipment to disposable technologies that eliminate cleaning validation steps and significantly reduce the risk of cross-contamination between batches. This transition enables faster changeovers and greater flexibility in multi-product facilities, directly addressing the industry's need for operational speed and sterility. According to Sartorius in February 2025, within the 'Annual Report 2024', the Bioprocess Solutions Division recorded a 12.7% increase in order intake in constant currencies, underscoring the recovering market demand for these advanced single-use manufacturing technologies.

Simultaneously, there is a decisive transition towards sustainable and energy-efficient laboratory equipment, driven by corporate net-zero pledges and rising operational costs. Laboratories are increasingly prioritizing centrifuges equipped with features such as hydrocarbon-based cooling, vacuum systems to reduce friction, and automatic standby modes to minimize electricity consumption during idle periods. This shift is supported by global initiatives that quantify and certify the environmental impact of research hardware, pushing manufacturers to innovate for lower carbon footprints. My Green Lab reported in 'A Year of Progress: My Green Lab’s Key Achievements in 2024' in January 2025 that the International Laboratory Freezer Challenge resulted in participants saving 31.8 million kWh of energy, a metric that highlights the sector's broader commitment to reducing the energy intensity of essential devices including separation and cold-storage systems.

Key Players Profiled in the Centrifugation Market

• Agilent Technologies, Inc.
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Eppendorf SE
• Corning Incorporated
• Hanil Scientific Inc.
• Daihan Scientific Co., Ltd.
• DLAB Scientific Co., Ltd.

Report Scope

In this report, the Global Centrifugation Market has been segmented into the following categories:

Centrifugation Market, by Product:

• Equipment
• Accessories

Centrifugation Market, by Model Type:

• Benchtop Centrifuges
• Floor-Standing Centrifuges

Centrifugation Market, by Application:

• Clinical Research
• Biotherapeutic Manufacturing
• Others

Centrifugation Market, by End-User:

• Hospitals and Blood Banks
• Biotechnology and Pharmaceutical Laboratories
• Academic and Research Institutes
• Others

Centrifugation Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Centrifugation Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.